Randox Quality Control is pleased to announce, as part of our continuing growth and development, the addition of Angiotensin Converting Enzyme (ACE) to our RIQAS Clinical Chemistry Programme. This will be added to Cycle 13, Sample 1 available in January 2016.
RIQAS is the largest international EQA scheme used by more than 32,000 laboratory participants in 123 countries. With large, international peer groups such as this you can be confident of the statistical validity of our extensive database of instrument and method results. If you wish to register for this parameter contact your local Randox Representative or email Acusera@randox.com.
For more information, visit www.RIQAS.com.